Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$5.1 - $10.0 $69,421 - $136,120
13,612 Added 97.72%
27,541 $190,000
Q1 2022

May 16, 2022

SELL
$8.34 - $14.69 $15,003 - $26,427
-1,799 Reduced 11.44%
13,929 $130,000
Q4 2021

Feb 14, 2022

BUY
$13.6 - $24.89 $213,900 - $391,469
15,728 New
15,728 $224,000
Q3 2021

Nov 15, 2021

SELL
$21.22 - $25.7 $453,577 - $549,337
-21,375 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$22.86 - $30.95 $488,632 - $661,556
21,375 New
21,375 $532,000
Q1 2021

May 17, 2021

SELL
$24.58 - $42.82 $308,331 - $537,134
-12,544 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$34.9 - $51.08 $437,785 - $640,747
12,544 New
12,544 $438,000

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.